Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 7.26 |   |
Earnings Per Share | -$2.06 |   |
Price To Sales Ratio | 49.68 |   |
Price To Book Ratio | 1.66 |   |
Price To Tangible Book Ratio | 1.80 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 473.2M |   |
Float (MRQ) | 70.72% |   |
Shares Outstanding (MRQ) | 33.9M |   |
Short Interest as a % of Float (MRQ) | 6.66% |   |
Shares Held By Institutions (MRQ) | 20.5M |   |
Margins | Industry Range | |
---|---|---|
Sales | $9.7M |   |
Gross Margin | N/A | |
Net Profit Margin | -637.19% |   |
EBIT Margin | -631.38% |   |
EBITDA Margin | -589.58% |   |
Operating Margins | -631.38% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 17.31 |   |
Quick Ratio (MRQ) | 17.31 |   |
Total Debt/Equity Ratio (MRQ) | 6.91 |   |
Debt/Common Equity Ratio (MRQ) | 6.91 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -25.18% |   |
Return on Assets | -26.76% |   |
Asset Turnover | 0.04 |   |
Receivables Turnover | N/A | |
Inventory Turnover | N/A |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | -63.56% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*ACET does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.22%